REtroperitoneal SArcoma Registry: an International Prospective Initiative

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2030

Conditions
Retroperitoneal Sarcoma
Trial Locations (22)

20133

RECRUITING

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

30322

RECRUITING

Winship Cancer Institute, Emory

32224

RECRUITING

Mayo Clinic, Jacksonville

33612

RECRUITING

Moffitt Cancer Center, Tampa

43210

RECRUITING

The Ohio State University, Columbus

90033

RECRUITING

University of Southern California (USC), Los Angeles

02115

RECRUITING

Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston

Unknown

RECRUITING

Peter MacCallum Cancer Center, Melbourne

NOT_YET_RECRUITING

Maisonneuve-Rosemont Hospital / University of Montreal, Montreal

RECRUITING

The Ottawa Hospital, Ottawa

RECRUITING

Mount Sinai / Princess Margaret, Toronto

RECRUITING

Institut Curie, Paris

NOT_YET_RECRUITING

University Medical Center and Medical Faculty Mannheim, University of Heidelberg, Mannheim

RECRUITING

Ludwig Maximilian University, Munich

RECRUITING

Veneto Institute of Oncology, Padua

RECRUITING

Ospedale Borgo Roma, Verona

RECRUITING

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw

RECRUITING

Institute of Oncology Ljubljana, Ljubljana

NOT_YET_RECRUITING

Samsung Medical Center, Seoul

NOT_YET_RECRUITING

"Hospital Clinico Universitario Virgen de la Arrixaca", Murcia

RECRUITING

University Hospital Birmingham (Queen Elizabeth), Birmingham

RECRUITING

Royal Marsden Hospital, London

All Listed Sponsors
collaborator

TransAtlantic Retroperitoneal Sarcoma Working Group

UNKNOWN

lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER